Image of the ALT C build at the UT health San Antonio Campus

Department of Microbiology, Immunology & Molecular Genetics

Our department is part of the Long School of Medicine at the UT Health San Antonio. Our faculty conducts research on the immune system, infectious agents and cancer.

The Department of Microbiology, Immunology & Molecular Genetics (MIMG) is the hub for research and education in Immunology and Microbiology at UT Health San Antonio, fostering a dynamic environment for scientific discovery and training.

Our mission is to advance knowledge in microbiology and immunology, microbial pathogenesis, host-pathogen interactions, tumor immunology, and autoimmunity, with the ultimate goal of developing novel therapeutics.

Committed to training the next generation of biomedical scientists, MIMG offers a range of educational and research opportunities, including:

Postdoctoral fellows play a vital role in our research mission. UT Health San Antonio supports their career development through the Office of Postdoctoral Affairs (OPA), and postdoctoral positions are available in most MIMG laboratories.


Upcoming Events

Recent News

About our Department

Learning and Training Opportunities

The Department of Microbiology, Immunology & Molecular Genetics supports a variety of learning and training opportunities in seminars, lectures and events, including

Contact the Program Coordinators at: immunity@uthscsa.edu

New Grant Awards

  • Dr. Dan Salamango was recently awarded a RO1 entitled: “Impact of Vpr induced epigenetic remodeling on HIV persistence”
  • Dr. Alexei Tumanov was recently awarded a Cancer Prevention and Research Institute of Texas grant (CPRIT) entitled: “Overcoming liver toxicity of anti-CD137 cancer immunotherapy”
  • Dr. Nu Zhang was recently awarded the VA Merit Award for his project entitled: “Targeting lymphoid tissue residency to boost tumor immunotherapies”
  • Dr. Yan Xiang and Dr. Peter Dube were recently awarded IIMS/CTSA award for their pilot project entitled: “Developing Hetero-bivalent Nanobodies Targeting Spike Receptor-Binding Domain as Therapeutics against SARS-CoV-2 Variants of Concern”
  • Dr. Ann Griffith was recently awarded NIH grant R56AI153626 grant entitled: “Causes and consequences of declining B cell-mediated central T cell tolerance throughout the lifespan”
  • Dr. Alexei Tumanov was recently awarded Cancer Prevention and Research Institute of Texas grant (CPRIT) entitled: “Targeting Lymphotoxin Beta Receptor in Sensory Neurons for Control of Chemotherapy-Induced Neuropathic Pain”
  • Dr. Michael Berton was recently awarded a Cancer Prevention and Research Institute of Texas grant (CPRIT) entitled: “High-Parameter Analysis, Sorting, and Imaging Flow Cytometry Shared Resource”

Events